VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $210,336 | -7.7% | 7,339 | -22.5% | 0.05% | -16.4% |
Q3 2022 | $228,000 | -16.8% | 9,473 | -5.3% | 0.06% | -12.9% |
Q2 2022 | $274,000 | -29.9% | 10,004 | -1.8% | 0.07% | -19.5% |
Q1 2022 | $391,000 | +6.8% | 10,190 | -10.9% | 0.09% | +11.5% |
Q4 2021 | $366,000 | -76.3% | 11,440 | -78.2% | 0.08% | -78.0% |
Q3 2021 | $1,545,000 | -14.8% | 52,419 | -1.8% | 0.35% | -14.7% |
Q2 2021 | $1,814,000 | +4.7% | 53,372 | +0.2% | 0.42% | -3.0% |
Q1 2021 | $1,732,000 | -21.7% | 53,284 | -13.2% | 0.43% | -22.5% |
Q4 2020 | $2,212,000 | -62.7% | 61,406 | -59.4% | 0.55% | -56.9% |
Q3 2020 | $5,930,000 | -40.5% | 151,421 | -44.2% | 1.28% | -42.5% |
Q2 2020 | $9,961,000 | +88.4% | 271,565 | +18.4% | 2.23% | +48.1% |
Q1 2020 | $5,286,000 | +1069.5% | 229,406 | +1385.1% | 1.50% | +1360.2% |
Q4 2019 | $452,000 | +86.0% | 15,447 | +69.7% | 0.10% | +45.1% |
Q3 2019 | $243,000 | -2.4% | 9,100 | -6.7% | 0.07% | +1.4% |
Q2 2019 | $249,000 | – | 9,752 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |